About 1 result found for searched term "JNJ-17203212" (0.141 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10840 | JNJ-17203212 | TRP Channel |
| JNJ-17203212 is a selective, highly effective, competitive TRPV1 antagonist. JNJ-17203212 was developed for research on pain management, such as migraines. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
